Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2017-03-09 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BUCHY (76750), Seine-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE COUTEL VANDECANDELAERE : revenue, balance sheet and financial ratios
PHARMACIE COUTEL VANDECANDELAERE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BUCHY (76750),
this company of category PME
shows in 2025 a net income positive of 279 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE COUTEL VANDECANDELAERE (SIREN 828248641)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
279 091 €
255 621 €
225 031 €
255 419 €
300 655 €
314 115 €
317 872 €
230 808 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE COUTEL VANDECANDELAERE generates positive net income of 279 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 231 k€ -> 279 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
279 091 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 121%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
120.98%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.401%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
566.826
304.833
206.629
150.907
235.103
203.852
150.244
120.98
Financial autonomy
13.038
22.624
30.112
36.992
24.825
29.116
34.619
39.401
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
120.982025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE COUTEL VANDECAN... (120.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.4%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE COUTEL VANDECAN... (39.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 195.31. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
166.788
254.209
333.381
394.921
123.461
177.181
182.89
195.315
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
195.312025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+10 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE COUTEL VANDECAN... (195.31) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE COUTEL VANDECANDELAERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE COUTEL VANDECANDELAERE is estimated at
4 433 393 €
(range 3 008 521€ - 6 956 605€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3008k€4433k€6956k€
4 433 393 €Range: 3 008 521€ - 6 956 605€
NAF 5 année 2025
Valuation method used
Net Income Multiple
279 091 €
×
15.9x
=4 433 394 €
Range: 3 008 522€ - 6 956 605€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE COUTEL VANDECANDELAERE with other companies in the same sector:
Frequently asked questions about PHARMACIE COUTEL VANDECANDELAERE
What is the revenue of PHARMACIE COUTEL VANDECANDELAERE ?
The revenue of PHARMACIE COUTEL VANDECANDELAERE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE COUTEL VANDECANDELAERE profitable?
Yes, PHARMACIE COUTEL VANDECANDELAERE generated a net profit of 279 k€ in 2025.
Where is the headquarters of PHARMACIE COUTEL VANDECANDELAERE ?
The headquarters of PHARMACIE COUTEL VANDECANDELAERE is located in BUCHY (76750), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE COUTEL VANDECANDELAERE ?
The tax return of PHARMACIE COUTEL VANDECANDELAERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE COUTEL VANDECANDELAERE operate?
PHARMACIE COUTEL VANDECANDELAERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart